Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Chastagner

Showing results (91-100 of 99) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 99 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2005
Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: a French Society of Pediatric Oncology StudyV Oyharcabal-Bourden, C Kalifa, J C Gentet, et al.
British Journal of Cancer|July 2, 1998
Unresectable localized neuroblastoma: improved survival after primary chemotherapy including carboplatin-etoposide. Neuroblastoma Study Group of the Société Française d'Oncologie Pédiatrique (SFOP)H Rubie, J Michon, D Plantaz, et al.
Revue Neurologique|May 3, 2011
[Medulloblastomas: review]L Taillandier, M Blonski, C Carrie, et al.
European Journal of Cancer (Oxford, England : 1990)|September 8, 2006
Treatment of high risk medulloblastomas in children above the age of 3 years: a SFOP studyJ Verlooy, V Mosseri, S Bracard, et al.
Leukemia|June 5, 2012
Genetic polymorphisms and childhood acute lymphoblastic leukemia: GWAS of the ESCALE study (SFCE)L Orsi, J Rudant, A Bonaventure, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie PédiatriqueH Rubie, O Hartmann, J Michon, et al.
Bone Marrow Transplantation|September 6, 2016
Prevalence and risk factors of iron overload after hematopoietic stem cell transplantation for childhood acute leukemia: a LEA studyA Sirvent, P Auquier, C Oudin, et al.
Blood Cancer Journal|January 21, 2017
Late effects in survivors of infantile acute leukemia: a study of the L.E.A programV Gandemer, J Bonneau, C Oudin, et al.
British Journal of Cancer|September 20, 2000
Adverse outcome of infants with metastatic neuroblastoma, MYCN amplification and/or bone lesions: results of the French society of pediatric oncologyV Minard, O Hartmann, M C Peyroulet, et al.
Pageof 10

Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2005
Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: a French Society of Pediatric Oncology StudyV Oyharcabal-Bourden, C Kalifa, J C Gentet, et al.
British Journal of Cancer|July 2, 1998
Unresectable localized neuroblastoma: improved survival after primary chemotherapy including carboplatin-etoposide. Neuroblastoma Study Group of the Société Française d'Oncologie Pédiatrique (SFOP)H Rubie, J Michon, D Plantaz, et al.
Revue Neurologique|May 3, 2011
[Medulloblastomas: review]L Taillandier, M Blonski, C Carrie, et al.
European Journal of Cancer (Oxford, England : 1990)|September 8, 2006
Treatment of high risk medulloblastomas in children above the age of 3 years: a SFOP studyJ Verlooy, V Mosseri, S Bracard, et al.
Leukemia|June 5, 2012
Genetic polymorphisms and childhood acute lymphoblastic leukemia: GWAS of the ESCALE study (SFCE)L Orsi, J Rudant, A Bonaventure, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie PédiatriqueH Rubie, O Hartmann, J Michon, et al.
Bone Marrow Transplantation|September 6, 2016
Prevalence and risk factors of iron overload after hematopoietic stem cell transplantation for childhood acute leukemia: a LEA studyA Sirvent, P Auquier, C Oudin, et al.
Blood Cancer Journal|January 21, 2017
Late effects in survivors of infantile acute leukemia: a study of the L.E.A programV Gandemer, J Bonneau, C Oudin, et al.
British Journal of Cancer|September 20, 2000
Adverse outcome of infants with metastatic neuroblastoma, MYCN amplification and/or bone lesions: results of the French society of pediatric oncologyV Minard, O Hartmann, M C Peyroulet, et al.
Pageof 10